Randomized controlled trial of single-agent glimepiride and pioglitazone in Japanese patients with type 2 diabetes: A comparative study.

J Diabetes Investig · 2011 · PMC4019308 · PMID 24843519

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

showed a trendno p-value reported

In the present study, glimepiride showed a trend towards decreasing HDL‐cholesterol, but this did not reach statistical significance.

also in 53,322 other papers

approached significanceno p-value reported

The changes for LDL‐cholesterol (−10.5 ± 30.4 vs −0.7 ± 29.7 mg/dL, P = 0.053) and triglycerides (−5.3 ± 49.8 vs −23.8 ± 74.4 mg/dL, P = 0.063) approached significance comparing glimepiride and pioglitazone, respectively.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.